| Literature DB >> 29358437 |
Tracy A Comans1,2, Kim-Huong Nguyen2,3, Brendan Mulhern4, Megan Corlis2,5, Li Li3, Alyssa Welch1,2, Susan E Kurrle2,6, Donna Rowen7, Wendy Moyle3, Sanjeewa Kularatna8, Julie Ratcliffe2,9.
Abstract
INTRODUCTION: Generic instruments for assessing health-related quality of life may lack the sensitivity to detect changes in health specific to certain conditions, such as dementia. The Quality of Life in Alzheimer's Disease (QOL-AD) is a widely used and well-validated condition-specific instrument for assessing health-related quality of life for people living with dementia, but it does not enable the calculation of quality-adjusted life years, the basis of cost utility analysis. This study will generate a preference-based scoring algorithm for a health state classification system -the Alzheimer's Disease Five Dimensions (AD-5D) derived from the QOL-AD. METHODS AND ANALYSIS: Discrete choice experiments with duration (DCETTO) and best-worst scaling health state valuation tasks will be administered to a representative sample of 2000 members of the Australian general population via an online survey and to 250 dementia dyads (250 people with dementia and their carers) via face-to-face interview. A multinomial (conditional) logistic framework will be used to analyse responses and produce the utility algorithm for the AD-5D. ETHICS AND DISSEMINATION: The algorithms developed will enable prospective and retrospective economic evaluation of any treatment or intervention targeting people with dementia where the QOL-AD has been administered and will be available online. Results will be disseminated through journals that publish health economics articles and through professional conferences. This study has ethical approval. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: best worst scaling; dementia; discrete choice experiment; quality adjusted life year; utility weight
Mesh:
Year: 2018 PMID: 29358437 PMCID: PMC5781065 DOI: 10.1136/bmjopen-2017-018996
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Process and methodology of the AD-5D project. AD-5D, Alzheimer ‘ s Disease Five Dimensions; BWS, best–worst scaling; QOL-AD, Quality of Life in Alzheimer’s disease.
Presentation of a DCE task
| Health description A | Health description B | |
| You have | You have | |
| You have | You have | |
| You have | You have | |
| You have | You have | |
| You have | You have | |
| You live in this state for | You live in this state for | |
| Which scenario do you think is better? | ☒ | ☐ |
DCE, discrete choice experiment.
Presentation of a BWS task
| Best | Health description | Worst |
| O | You have | O |
| O | You have | O |
| O | You have | O |
| O | You have | O |
| O | You have | O |
BWS, best–worst scaling.